First, do no harm: direct-to-consumer genetic testing

Genet Med. 2019 Feb;21(2):510-511. doi: 10.1038/s41436-018-0071-z. Epub 2018 Jun 14.

Authors

Jennifer Schleit¹, Lorraine V Naylor², Fuki M Hisama³

Affiliations

¹ Blueprint Genetics (J.S.), San Francisco, California, USA. [email protected].
² Seattle Cancer Care Alliance (L.V.N.), Seattle, Washington, USA.
³ Department of Medicine Division of Medical Genetics (F.M.H), University of Washington, Seattle, Washington, USA.

PMID: 29904164
DOI: 10.1038/s41436-018-0071-z

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Direct-To-Consumer Screening and Testing*
Female
Genes, BRCA2
Genetic Testing* / economics
Genetic Testing* / ethics
Humans
Middle Aged
Risk Assessment